Health
Stryker Agrees to Buy Inari Medical for $80 Per Share
- Inari’s blood clot devices will expand Stryker’s reach
- Acquisition comes during a surge in medical device demand
This article is for subscribers only.
Medical device maker Stryker Corp. agreed to purchase Inari Medical Inc. for about $4.9 billion to expand its offerings in the fast-growing area of treating blood clots in the legs and lungs.
The boards of both companies approved the deal and Stryker will commence with a cash offer of $80 per share, it said late Monday.